#netter1 검색 결과
VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost
Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana
Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism
PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…
#Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal #NETTER1 study with targeted #RadioligandTherapy #Lutathera 1stoncology.com/blog/novartis-…
PRRT goes mainstream. exciting times ahead! #PRRT #NETcancer #NETTER1 abc6.com/story/30125072…
#Therametrics subsidiary has been selected to extend international #PhaseIII clinical trial #Netter1 ow.ly/CtP1Y
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism
PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana
Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO
Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…
VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost
PRRT goes mainstream. exciting times ahead! #PRRT #NETcancer #NETTER1 abc6.com/story/30125072…
#Therametrics subsidiary has been selected to extend international #PhaseIII clinical trial #Netter1 ow.ly/CtP1Y
VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost
Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana
Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO
Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism
PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
Something went wrong.
Something went wrong.
United States Trends
- 1. #happybdayTYGA N/A
- 2. $SENS $0.70 Senseonics CGM N/A
- 3. $APDN $0.20 Applied DNA N/A
- 4. $LMT $450.50 Lockheed F-35 N/A
- 5. Peggy 35.4K posts
- 6. Sonic 06 3,094 posts
- 7. GeForce Season 2,518 posts
- 8. Comey 45.2K posts
- 9. Halligan 17.3K posts
- 10. Zeraora 17.6K posts
- 11. Stargate 4,253 posts
- 12. Berseria 5,734 posts
- 13. Cory Mills 36.2K posts
- 14. $NVDA 47.9K posts
- 15. Dearborn 401K posts
- 16. #ComunaONada 4,524 posts
- 17. Ryan Wedding 7,688 posts
- 18. International Men's Day 97.9K posts
- 19. Ronaldo 281K posts
- 20. Rick Hendrick 1,673 posts